These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers. Pageaux GP, Micallef J, Nataf MB, Levron JC, Lacarelle B, Le Moing JP, Bouhours P, Blin O. Br J Clin Pharmacol; 2001 Feb; 51(2):164-8. PubMed ID: 11259989 [Abstract] [Full Text] [Related]
3. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects. Rohatagi S, Gillen M, Aubeneau M, Jan C, Pandit B, Jensen BK, Rhodes G. Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males. Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC. Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571 [Abstract] [Full Text] [Related]
12. Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors. Han K, Jin JY, Marchand M, Eppler S, Choong N, Hack SP, Tikoo N, Bruno R, Dresser M, Musib L, Budha NR. Cancer Chemother Pharmacol; 2015 Nov; 76(5):917-24. PubMed ID: 26365290 [Abstract] [Full Text] [Related]
13. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study. Nunes T, Rocha JF, Vaz-da-Silva M, Falcão A, Almeida L, Soares-da-Silva P. Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor. Moore KH, Cass LM, Dallow N, Hardman TC, Jones A, Boyce M, Prince WT. Eur J Clin Pharmacol; 2001 Jun; 56(11):805-11. PubMed ID: 11294370 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers. Jones A, Wang-Smith L, Pham T, Laliberte K. J Cardiovasc Pharmacol; 2014 Mar; 63(3):227-32. PubMed ID: 24603117 [Abstract] [Full Text] [Related]
16. Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d. Stockis A, De Bruyn S, Gengler C, Rosillon D. Int J Clin Pharmacol Ther; 2002 May; 40(5):221-7. PubMed ID: 12051574 [Abstract] [Full Text] [Related]
17. Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers. Miceli JJ, Wilner KD, Hansen RA, Johnson AC, Apseloff G, Gerber N. Br J Clin Pharmacol; 2000 May; 49 Suppl 1(Suppl 1):5S-13S. PubMed ID: 10771448 [Abstract] [Full Text] [Related]
20. Population pharmacokinetic modelling and simulation of single and multiple dose administration of meloxicam in cats. Lehr T, Narbe R, Jöns O, Kloft C, Staab A. J Vet Pharmacol Ther; 2010 Jun 01; 33(3):277-86. PubMed ID: 20557445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]